Login
← Go Back
Hikal
HIKAL · Pharma > Pharmaceuticals & Drugs · Chairman: Jai Hiremath · MD: Jai Hiremath · Listing date: Feb. 15, 2001 · Employees: 1528 · Navi Mumbai · http://www.hikal.com
Stock Price vs Company Growth
1d
4.1%
1w
9.2%
1m
1.0%
3m
7.4%
6m
34.6%
1y
43.2%
5y
7.7%
10y
8.9%
all
9.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 243 4.1%
217
283
Company Overview
Sales
1,699 Cr
Growth: -0.5%
Profit after Tax
10.1 Cr
Growth: -84.0%
Small Cap
2,993 Cr
P/E: 299.6x
Industry P/E: 33.2x
Fundamentals
Sales (Cr) ₹ 1,699
Growth -0.5%
EBITDA 13.4%
P/S 1.8x
Dividend 0.3%
P/E 299.6x
Book Value ₹ 97.7
PEG Ratio -557.2x
ROE 0.8%
P/B 2.5x
Shareholding Pattern
Institutions
Government Pension Fund Global
2.31 %
Promoters
Kalyani Investment Company Limited
31.36 %
Shri Badrinath Investment Pvt Ltd
16.15 %
Shri Rameshwara Investment Pvt Ltd
7.96 %
Sugandha Jai Hiremath
7.84 %
Bf Investment Limited
2.65 %
Others
Si Investments And Broking Private Limited
1.62 %
Llp
0.4 %
Iepf
0.21 %
Increase    Decrease    No change
Company Profile Detailed
Established in 1988 Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals industries. They provide world-class Active Ingredients, Intermediates and R&D services and solutions in a safe, secure and confidential manner. Their advanced infrastructure has been inspected and approved by globally recognized bodies such as the USFDA. Hikal is a company built on enduring relationships.
Belongs to (10 Indices) view more
Investors (61)
ritu.aru...
idfc.ste...
bf.inves...
Followers (6)
mike2
nitin29
vishal48